An aldose reductase inhibitor, TAT, prevents electroretinographic abnormalities and ADP-induced hyperaggregability in streptozotocin-induced diabetic rats.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples